Evidence map›Paper›PMID 34916544›Full record

ArticleScientific reports2021

Association between albumin infusion and outcomes in patients with acute kidney injury and septic shock.

Chenglong Ge, Qianyi Peng, Wei Chen, Wenchao Li, Lina Zhang, Yuhang Ai

Abstract read
In one paragraph

Article in Scientific reports, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Observational
  9. Article
  10. Article
  11. Article
  12. Article
  13. Observational
  14. Article
  15. Article
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Chenglong GeDepartment of Critical Care Medicine, Xiangya Hospital, Central South University, Changsha, 410008, People's Republic of China.
Qianyi PengDepartment of Critical Care Medicine, Xiangya Hospital, Central South University, Changsha, 410008, People's Republic of China.
Wei ChenDepartment of Critical Care Medicine, Xiangya Hospital, Central South University, Changsha, 410008, People's Republic of China.
Wenchao LiDepartment of Critical Care Medicine, Xiangya Hospital, Central South University, Changsha, 410008, People's Republic of China.
Lina ZhangDepartment of Critical Care Medicine, Xiangya Hospital, Central South University, Changsha, 410008, People's Republic of China.
Yuhang AiDepartment of Critical Care Medicine, Xiangya Hospital, Central South University, Changsha, 410008, People's Republic of China. ayhicu1978@csu.edu.cn.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Septic shock with acute kidney injury (AKI) is common in critically ill patients. Our aim was to evaluate the association between albumin infusion and outcomes in patients with septic shock and AKI. Medical Information Mart for Intensive Care (MIMIC)-III was used to identify patients with septic shock and AKI. Propensity score matching (PSM) was employed to balance the baseline differences. Cox proportional hazards model, Wilcoxon rank-sum test, and logistic regression were utilized to determine the associations of albumin infusion with mortality, length of stay, and recovery of kidney function, respectively. A total of 2861 septic shock patients with AKI were studied, including 891 with albumin infusion, and 1970 without albumin infusion. After PSM, 749 pairs of patients were matched. Albumin infusion was associated with improved 28-day survival (HR 0.72; 95% CI 0.59-0.86; P = 0.002), but it was not difference in 90-day mortality between groups (HR 0.94; 95% CI 0.79-1.12; P = 0.474). Albumin infusion was not associated with the renal function recovery (HR 0.91; 95% CI 0.73-1.13; P = 0.393) in either population. Nevertheless, subgroup analysis showed that albumin infusion was distinctly associated with reduced 28-day mortality in patients with age > 60 years. The results need to be validated in more randomized controlled trials.

Indexed as

Acute Kidney InjuryAgedAged, 80 and overAge FactorsAlbuminsFemaleHumansInfusions, IntravenousKidneyLength of StayMaleMiddle AgedPropensity ScoreRecovery of FunctionShock, SepticSurvival RateAlbumins

Identifiers

PMID34916544
PMCPMC8677767

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.